New Data Blocking and Interoperability Rules: Implications for Healthcare Providers, Payers, Vendors

Ms. Halstead is a member of the firm’s Life Sciences Health Industry Group, practicing in the area of healthcare regulatory law. Her practice focuses on the intersection of healthcare and technology, relying on her significant expertise in Medicare and Medicaid reimbursement, and HIPAA, health information privacy, Anti-Kickback Statute, beneficiary inducement, Stark, and 60 Day Overpayment Rule compliance to inform digital health strategies and arrangements. Ms. Halstead has extensive experience counselling healthcare providers, pharmaceutical and medical device manufacturers, and technology companies on collaboration agreements, value-based arrangements, strategic data partnerships, mobile health solutions and applications, connected devices, and breach incident response.

Mr. Johnson is a nationally recognized lawyer for healthcare innovation. He helps his clients develop and launch innovative business models designed to improve healthcare quality, accessibility, and affordability. Mr. Johnson serves as outside general counsel for digital health companies, healthcare providers, and life science companies that are transforming healthcare through innovation and cutting-edge science and technology. He regularly advises investors, senior executives, and corporate boards on the strategic threats and opportunities arising from emerging technologies and new laws and regulations, especially those affecting the healthcare industry. Mr. Johnson has considerable experience advising clients on a variety of regulatory and corporate matters and in structuring and negotiating healthcare transactions, including M&As, joint ventures, licensing agreements, and financings. He frequently writes and lectures about issues emerging from the intersection of law, science, and technology. Mr. Johnson currently serves on the Board of Directors of the American Health Lawyers Association and serves as an adjunct professor of health law and policy for the University of Saint Thomas Health Care MBA program.